Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $141.10 | Total: $705.50 |
| 1 | 10 | $119.52 | Total: $1,195.20 |
| 1 | 25 | $101.26 | Total: $2,531.50 |
| 1 | 50 | $86.32 | Total: $4,316.00 |
| 1 | 100 | $74.70 | Total: $7,470.00 |
Overview
Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.
Chemical Properties
| Molecular Formula | C41H36ClF3N2O4S |
| Molecular Weight | 745.25 |
| CAS Numbers | 865200-20-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(N1C(CCNS(CC2=C(C(F)(F)F)C=CC=C2)(=O)=O)=C(CCCC3=CC=C(C(O)=O)C=C3)C=4C1=CC=C(Cl)C4)(C5=CC=CC=C5)C6=CC=CC=C6 |
Storage and Handling
0C Short Term, -20C Long Term
References
Duvernay MT, et al. Platelet Lipidomic Profiling Novel Insight into Cytosolic Phospholipase A2? Activity and Its Role in Human Platelet Activation. Biochemistry. 2015 Sep 15;54[36] 5578-88.